MedPath

The Chinese University of Hong Kong

The Chinese University of Hong Kong logo
🇨🇳China
Ownership
Private
Established
1963-01-01
Employees
-
Market Cap
-
Website
http://www.cuhk.edu.hk

Effects of HMG-coA Reductase Inhibitor on Rheumatoid Arthritis

Phase 2
Completed
Conditions
Rheumatoid Arthritis
Interventions
Drug: Placebo
First Posted Date
2007-11-08
Last Posted Date
2011-01-27
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
150
Registration Number
NCT00555230
Locations
🇨🇳

School of Pharmacy CUHK, Hong Kong, China

An Analysis of Peripheral Blood T Cell Subsets on Rheumatoid Arthritis

Phase 2
Completed
Conditions
Rheumatoid Arthritis
Interventions
First Posted Date
2007-11-08
Last Posted Date
2008-05-09
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
10
Registration Number
NCT00555542
Locations
🇨🇳

Department of Medicine and Therapeutics, Hong Kong, China

Cost-effectiveness of Two Painkillers for Treating Pain After Limb Injuries

Phase 2
Completed
Conditions
Soft Tissue Injuries
Interventions
First Posted Date
2007-09-12
Last Posted Date
2021-06-08
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
782
Registration Number
NCT00528658
Locations
🇭🇰

Prince of Wales Hospital, Sha Tin, NT, Hong Kong

The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria

Phase 4
Withdrawn
Conditions
Systemic Lupus Erythematosus
Nephritis
Proteinuria
Interventions
Drug: Multivitamin
First Posted Date
2007-07-30
Last Posted Date
2015-08-04
Lead Sponsor
Chinese University of Hong Kong
Registration Number
NCT00508898

Anal Fistula Plug for High-type Anal Fistulae

Not Applicable
Terminated
Conditions
High-type Anal Fistulae
Interventions
Device: Anal fistula plug
First Posted Date
2007-06-15
Last Posted Date
2014-02-13
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
10
Registration Number
NCT00487071
Locations
🇨🇳

Department of Surgery, Prince of Wales Hospital, Hong Kong SAR, China

Laparoscopic Assisted Versus Open Resection for Colorectal Carcinoma

Phase 3
Completed
Conditions
Colorectal Carcinoma
First Posted Date
2007-06-12
Last Posted Date
2009-03-31
Lead Sponsor
Chinese University of Hong Kong
Registration Number
NCT00485316
Locations
🇨🇳

Prince of Wales Hospital, Hong Kong SAR, China

A Prospective Randomized Trial Comparing Laparoscopic Nissen Against Anterior Partial Fundoplication in Treating Gastroesophageal Reflux Disease Among Chinese Patients

Phase 3
Conditions
Gastroesophageal Reflux Disease
First Posted Date
2007-05-30
Last Posted Date
2007-05-30
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
100
Registration Number
NCT00480285
Locations
🇭🇰

Philip Chiu, Hong Kong, Hong Kong

Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma

Phase 3
Completed
Conditions
Hepatocellular Carcinoma
Interventions
Procedure: TACE
Procedure: TEA with LEM
First Posted Date
2007-05-01
Last Posted Date
2015-01-26
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
98
Registration Number
NCT00467974
Locations
🇭🇰

Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong

🇭🇰

Department of Diagnostic Radiology and Organ Imaging, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong

🇭🇰

Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong

Electroacupuncture for Postoperative Ileus After Laparoscopic Colorectal Surgery

Phase 3
Completed
Conditions
Postoperative Ileus
Interventions
Procedure: Electroacupuncture
Procedure: Sham Acupuncture
Other: No Acupuncture
First Posted Date
2007-04-23
Last Posted Date
2011-04-21
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
165
Registration Number
NCT00464425
Locations
🇨🇳

Surgical Wards 4C and 4D, Prince of Wales Hospital, Shatin, Hong Kong SAR, China

Herbal Treatment for Perennial Allergic Rhinitis

Phase 2
Completed
Conditions
Perennial Allergic Rhinitis
Interventions
Drug: Shi-Bi-Lin
Other: Placebo
First Posted Date
2007-04-05
Last Posted Date
2010-01-06
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
126
Registration Number
NCT00456755
Locations
🇭🇰

Department of ENT, Prince of Wales Hospital, Hong Kong, Hong Kong

🇭🇰

Department of ENT, Yan Chai Hospital, Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath